Mirati Therapeutics reported $1.25B in Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acceleron Pharma XLRN:US $ 787.85M 48.2M
Agios Pharmaceuticals AGIO:US $ 1541.5M 333.1M
Alnylam Pharmaceuticals ALNY:US $ 3472.31M 37.12M
Amgen AMGN:US $ 64993M 5220M
Astellas Pharma 4503:JP Y 2261508M 12052M
AstraZeneca AZN:LN 107221M 33580M
Bayer BAYN:GR € 116549M 2122M
Biocryst Pharmaceuticals BCRX:US $ 265.76M 11.52M
Bluebird Bio BLUE:US $ 1339.64M 114.82M
Bristol Myers Squibb BMY:US $ 110893M 96M
Eisai 4523:JP Y 1140111M 10770M
Eli Lilly And LLY:US $ 48187M 378M
Exelixis EXEL:US $ 2447.74M 80.47M
Gilead Sciences GILD:US $ 67098M 886M
GlaxoSmithKline GSK:LN 78689M 1678M
Moderna Inc MRNA:US 20.92B 4.77B
Nektar Therapeutics NKTR:US $ 1277.24M 94.11M
Novartis NOVN:VX SF 121209M 2806M
Puma Biotechnology PBYI:US $ 226.29M 33.71M
Sarepta Therapeutics SRPT:US $ 2662.22M 96.86M
Seattle Genetics SGEN:US $ 3977.88M 25.72M
Spectrum Pharmaceuticals SPPI:US $ 147.8M 27.24M
Takeda 4502:JP Y 12560273M 96961M
Ultragenyx Pharmaceutical RARE:US $ 1484.8M 27.64M
YTE INCY:US $ 4198.83M 294.21M